Leap Therapeutics, Inc. (LPTX) stock price moved -30.19% away from 20-Days Simple Moving Average, -40.09% from 50-Days Simple Moving Average and separated -73.72% from 200 Days Simple Moving Average. Leap Therapeutics, Inc. (LPTX) reported gain 4.70% in recent buying and selling session with closing price of $ 1.56. The stock’s traded 1.72 million shares in session while it holds an average volume of 0.26 million shares. The LPTX switched 15.56% away from its 52 week minimum and distanced -84.78% from its 52 week peak. The volatility change in the previous week has observed by 10.62% and experienced of 14.17% change in the last month.
The short ratio in the company’s stock is documented at 0.30 and the short float is around of 0.39%. The Company kept a record of 19.80 million floated shares and 21.68 million shares outstanding. The average true range of the stock is observed at 0.30 and the relative strength index of the stock is recorded at 33.46.
Leap Therapeutics, Inc. (LPTX) Stock Profitability Levels:
The company made Return on equity of -271.40% in last 12 months period. Return on assets ratio of the Company was -96.60%.
Looking out over a next 5-year period, analysts expect the company to see its earnings go up by -2.49%, annually. Analyst established EPS growth expected to grow of -65.20% for this year and EPS growth for next year is likely to attain at 21.80%.
Looking about the past performance history, the company jumped 8.33% for the last five trades and exhausted -38.58% in one month period. The stock deteriorated -63.97% during the past three month period and discounted -78.66% in half year. During the yearly overview it downgraded -75.00% and shown -22.00% year to date performance.